Evidence map›Paper›PMID 32960951›Full record

ArticleInvestigative ophthalmology & visual science2020

Long-Term Investigation of Retinal Function in Patients with Achromatopsia.

Michalis Georgiou, Navjit Singh, Thomas Kane, Serena Zaman, Nashila Hirji, Jonathan Aboshiha, Neruban Kumaran, Angelos Kalitzeos, Joseph Carroll, Richard G Weleber and 1 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Disease Progression inCurrent issues in molecular biology · 2021
    Article
  9. Observational
  10. Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Michalis GeorgiouUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Navjit SinghUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Thomas KaneUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Serena ZamanUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Nashila HirjiUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Jonathan AboshihaUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Neruban KumaranUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Angelos KalitzeosUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Joseph CarrollDepartment of Ophthalmology & Visual Sciences, Medical College of Wisconsin, Wauwatosa, Wisconsin, United States.
Richard G WeleberCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Michel MichaelidesUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Moorfields Eye Hospital · GBMoorfields Eye Hospital NHS Foundation Trust · GBUniversity College London · GBMedical College of Wisconsin · USOregon Health & Science University · US

Funding

Assessing Photoreceptor Structure and Function in Normal and Diseased RetinaeR01EY017607 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Joseph Carroll · 2008 to 2026
$8.3M
Department of HealthNEI NIH HHS R01 EY017607Wellcome Trust 099173/Z/12/Z
6 · The paper itself

Abstract

Purpose: To investigate the long-term natural history of retinal function of achromatopsia (ACHM). Methods: Subjects with molecularly confirmed ACHM were recruited in a prospective cohort study of mesopic microperimetry. Coefficient of repeatability and intraclass correlation coefficient (ICC) of mean sensitivity (MS) were calculated. Best-corrected visual acuity (BCVA), bivariate contour ellipse area (BCEA), contrast sensitivity (CS), MS, total volume (VTOT), and central field volume (V5°) from volumetric and topographic analyses were acquired. Correlation of functional parameters with structural findings from optical coherence tomography (OCT) was performed. Results: Eighteen subjects were recruited. Mean follow-up was 7.2 years. The MS test-retest repeatability coefficient was 1.65 decibels (dB), and the ICC was 0.973 (95% confidence interval, 0.837-0.98). Mean MS was similar for right and left eyes (16.97dB and 17.14dB, respectively). A negative significant correlation between logMAR BCVA and the retinal sensitivity indices (MS, VTOT, V5°) was found. A significant negative correlation between logCS and MS, VTOT, and V5° was also observed. BCVA and BCEA improved during follow-up. Mean CS, MS, VTOT, and V5° at final follow-up were similar to baseline. MS was similar between CNGA3- and CNGB3-ACHM. Patients with and without the presence of a foveal ellipsoid zone on OCT had similar MS (16.64 dB and 17.17 dB, respectively). Conclusions: We demonstrate a highly reproducible assessment of MS. Retinal function including MS, volumetric indices, and CS are stable in ACHM. Improvement of fixation stability and small changes of BCVA over time may be part of the natural history of the disease.

Indexed as

Visual AcuityAdolescentAdultAgedChildColor Vision DefectsFemaleFollow-Up StudiesFovea CentralisHumansMaleMiddle AgedProspective StudiesTime FactorsTomography, Optical CoherenceVisual Fields

Identifiers

PMID32960951
PMCPMC7509756
OpenAlexW3088468351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.